RSV — Drug Target

3 drugs 3 marketed

All drugs that target RSV — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

vaccine · Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]

Marketed (3)

Abrysvo · Pfizer · vaccine · Infectious Disease
ABRYSVO is a vaccine that protects against respiratory syncytial virus (RSV).
Beyfortus · AstraZeneca · Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] · Infectious Disease
BEYFORTUS is a monoclonal antibody that targets RSV.
RSVpreF Vaccine · Pfizer Inc. · vaccine · Immunology